260 related articles for article (PubMed ID: 1512328)
1. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.
Dalla-Volta S; Palla A; Santolicandro A; Giuntini C; Pengo V; Visioli O; Zonzin P; Zanuttini D; Barbaresi F; Agnelli G
J Am Coll Cardiol; 1992 Sep; 20(3):520-6. PubMed ID: 1512328
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up.
Meneveau N; Schiele F; Metz D; Valette B; Attali P; Vuillemenot A; Grollier G; Elaerts J; Mossard JM; Viel JF; Bassand JP
J Am Coll Cardiol; 1998 Apr; 31(5):1057-63. PubMed ID: 9562007
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial.
Sors H; Pacouret G; Azarian R; Meyer G; Charbonnier B; Simonneau G
Chest; 1994 Sep; 106(3):712-7. PubMed ID: 8082346
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism.
Meyer G; Sors H; Charbonnier B; Kasper W; Bassand JP; Kerr IH; Lesaffre E; Vanhove P; Verstraete M
J Am Coll Cardiol; 1992 Feb; 19(2):239-45. PubMed ID: 1732347
[TBL] [Abstract][Full Text] [Related]
5. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA
Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768
[TBL] [Abstract][Full Text] [Related]
6. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
Goldhaber SZ; Agnelli G; Levine MN
Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
[TBL] [Abstract][Full Text] [Related]
7. Comparison of alteplase versus heparin for resolution of major pulmonary embolism.
Konstantinides S; Tiede N; Geibel A; Olschewski M; Just H; Kasper W
Am J Cardiol; 1998 Oct; 82(8):966-70. PubMed ID: 9794353
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
[TBL] [Abstract][Full Text] [Related]
9. [Tissue plasminogen activator (alteplase) in acute massive pulmonary embolism. A pilot study].
Lang M; Charbonnier B; Quilliet L; Pacouret G; Poitrineau O; Mannara R; Neel G; Desveaux B; Raynaud P; Brochier ML
Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1803-11. PubMed ID: 2514632
[TBL] [Abstract][Full Text] [Related]
10. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
Konstantinides S; Geibel A; Heusel G; Heinrich F; Kasper W;
N Engl J Med; 2002 Oct; 347(15):1143-50. PubMed ID: 12374874
[TBL] [Abstract][Full Text] [Related]
11. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.
Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R
J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043
[TBL] [Abstract][Full Text] [Related]
12. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
Arnout J; Simoons M; de Bono D; Rapold HJ; Collen D; Verstraete M
J Am Coll Cardiol; 1992 Sep; 20(3):513-9. PubMed ID: 1512327
[TBL] [Abstract][Full Text] [Related]
13. Acute pulmonary embolism treated with tissue plasminogen activator.
Goldhaber SZ; Vaughan DE; Markis JE; Selwyn AP; Meyerovitz MF; Loscalzo J; Kim DS; Kessler CM; Dawley DL; Sharma GV
Lancet; 1986 Oct; 2(8512):886-9. PubMed ID: 2876327
[TBL] [Abstract][Full Text] [Related]
14. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism.
Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H
Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621
[TBL] [Abstract][Full Text] [Related]
16. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH
Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558
[TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
Kucher N; Boekstegers P; Müller OJ; Kupatt C; Beyer-Westendorf J; Heitzer T; Tebbe U; Horstkotte J; Müller R; Blessing E; Greif M; Lange P; Hoffmann RT; Werth S; Barmeyer A; Härtel D; Grünwald H; Empen K; Baumgartner I
Circulation; 2014 Jan; 129(4):479-86. PubMed ID: 24226805
[TBL] [Abstract][Full Text] [Related]
18. Medical compared with surgical treatment for massive pulmonary embolism.
Gulba DC; Schmid C; Borst HG; Lichtlen P; Dietz R; Luft FC
Lancet; 1994 Mar; 343(8897):576-7. PubMed ID: 7906331
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure.
Kline JA; Steuerwald MT; Marchick MR; Hernandez-Nino J; Rose GA
Chest; 2009 Nov; 136(5):1202-1210. PubMed ID: 19542256
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
